Cargando…
Sorafenib Combined with Cryoablation to Treat Unresectable Hepatocellular Carcinoma
OBJECTIVE: To evaluate the efficacy and tolerability of sorafenib combined with cryoablation in treating unresectable hepatocellular carcinoma (HCC). METHODS: Patients with unresectable advanced HCC received cryoablation and sorafenib at a dose of 400 mg twice daily in 4-week cycles on the same day...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag Berlin Heidelberg
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587556/ https://www.ncbi.nlm.nih.gov/pubmed/23467380 http://dx.doi.org/10.1007/s11670-011-0188-y |